Zoonotic Tuberculosis: Navigating Diagnostic Challenges and TB-IRIS

Zoonotic tuberculosis, caused by Mycobacterium bovis, remains a significant diagnostic challenge that can mimic malignancy and evade standard detection methods for years. Clinicians must maintain a high index of suspicion for patients with a history of exposure to infected livestock, even when initial screenings are negative. Effective management requires precise diagnostic sampling, as improper tissue preservation—such as the use of formalin—can render definitive identification impossible. Furthermore, practitioners must be prepared to manage tuberculosis-associated immune reconstitution syndrome (TB-IRIS), a paradoxical inflammatory response that often appears as treatment failure.

Understanding the Zoonotic Risk of M. bovis

Mycobacterium bovis is the primary pathogen responsible for bovine tuberculosis, a zoonotic disease that can be transmitted from cattle to humans. Zoonotic tuberculosis is a form of human tuberculosis caused by M. bovis. While clinical manifestations are often indistinguishable from those of Mycobacterium tuberculosis—ranging from pulmonary involvement to cervical lymphadenitis—the two pathogens differ in their susceptibility to standard drug regimens.

A critical distinction is the intrinsic resistance of M. bovis to pyrazinamide. Standard antitubercular therapy typically includes pyrazinamide during the initial two-month phase. If a clinician fails to identify the pathogen as M. bovis and relies on standard six-month protocols, the treatment may be insufficient. Guidelines suggest that when M. bovis is confirmed or suspected, the continuation phase of treatment with rifampicin and isoniazid should be extended to seven months, resulting in a total treatment duration of nine months.

The Diagnostic Pitfall: Formalin and Tissue Preservation

The diagnostic process is frequently hampered by the way surgical specimens are handled. For the definitive diagnosis of mycobacterial infections, viable tissue is essential. When a lymph node is removed for suspected tuberculosis, it is common practice to send the specimen to pathology for histopathological examination in formalin.

However, formalin is a potent fixative that cross-links proteins and DNA, effectively killing mycobacteria. If the entire sample is placed in formalin, the ability to perform cultures or molecular sub-speciation is lost. Because mycobacterial load in lymph node tissue can be “paucibacillary” (low in germs), failing to reserve a native, unfixed portion of the tissue for microbiological testing often results in a missed diagnosis. Clinicians should ensure that any biopsy suspected of harboring mycobacteria includes a portion of fresh, native tissue for culture and PCR testing.

Managing Paradoxical Reactions: TB-IRIS

Clinicians treating extrapulmonary tuberculosis must be alert to the possibility of a paradoxical reaction known as tuberculosis-associated immune reconstitution syndrome (TB-IRIS). TB-IRIS occurs when an individual’s immune system begins to recover and initiates a hyper-inflammatory response to the antigens released by dying bacteria.

Clinically, this often manifests weeks after the initiation of effective antitubercular therapy. Patients may experience increased lymph node swelling or persistent wound drainage, which can be misidentified as treatment failure or drug resistance. In cases of suspected IRIS, it is crucial to continue the antitubercular therapy while managing the inflammatory response with systemic corticosteroids. Stopping the antibiotic regimen in the belief that it is failing will only exacerbate the underlying infection.

Key Considerations for Clinical Practice

• Zoonotic History: Always document occupational or environmental exposure to livestock, as M. bovis may remain latent for years.
• Sample Handling: Never place the entire biopsy specimen in formalin; always reserve native tissue for culture and molecular diagnostics.
• Paradoxical Reactions: Recognize that increased swelling during treatment may indicate a robust immune response (TB-IRIS) rather than drug resistance.
• Multidisciplinary Approach: Successful management of complex extrapulmonary TB requires close coordination between surgeons, pathologists, and infectious disease specialists.